Clinical Outcomes and Patency after Transjugular Intrahepatic Portosystemic Shunt Reduction for Overshunting Adverse Events

医学 经颈静脉肝内门体分流术 肝性脑病 不利影响 腹水 门脉高压 置信区间 外科 肝硬化 回顾性队列研究 门体分流术 内科学 肝病 支架 胃肠病学
作者
Raj J. Shah,Murad M. Alqadi,Madhavi Duvvuri,Yoon-Jin Kim,Ravi Tyagi,R. Peter Lokken,Ron C. Gaba
出处
期刊:Journal of Vascular and Interventional Radiology [Elsevier BV]
卷期号:33 (12): 1507-1512 被引量:5
标识
DOI:10.1016/j.jvir.2022.08.007
摘要

To assess clinical outcomes and patency after transjugular intrahepatic portosystemic shunt (TIPS) reduction for overshunting adverse events.This multicenter, retrospective observational study included 33 patients (male-to-female ratio, 20:13; mean age, 59 years; mean Model for End-Stage Liver Disease [MELD] score, 15) who underwent TIPS reduction between 2007 and 2020. Procedure indications included medically refractory hepatic encephalopathy (HE) (85%), post-TIPS hepatic insufficiency (HI) (12%), and heart failure (3%). The measured outcomes included improvement in HE (classified using the West Haven system) and HI, patency of reduced TIPS, and transplant-free survival (TFS).TIPS reductions were successfully performed using parallel stent (94%) or other (6%) techniques at a median of 120 days after TIPS creation (HE, median, 164 days; HI, median, 5 days). The portosystemic pressure gradient increased from a mean of 10 to 17 mm Hg (P < .001). The overall HE rate after TIPS reduction was 54%; HE was persistent, improved, and resolved in 21%, 32%, and 46% cases, respectively. In patients with HI, the MELD score increased from a mean of 22 before TIPS to 34 after TIPS (P = .061), but without improvement (0%) in HI after TIPS reduction (mean MELD score, 30; P = .266). Recurrent ascites occurred in 14% of the patients. The median shunt patency was 961 days (95% confidence interval, 476-1,447). The 30-day, 6-month, 1-year, and 3-year shunt patency rates were 92%, 81%, 74%, and 37%, respectively. The median TFS was not reached. The 30-day, 6-month, 1-year, and 3-year survival rates were 97%, 90%, 81%, and 60%, respectively.Although TIPS reduction may be an effective and durable approach to treat post-TIPS medically refractory HE, shunt reduction may not achieve meaningful benefit for HI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
狂野的山菡完成签到,获得积分10
1秒前
荼蘼发布了新的文献求助10
1秒前
2秒前
2秒前
科研通AI2S的应助被开放满天采纳,获得10
4秒前
4秒前
村民完成签到 ,获得积分10
4秒前
molihuakai的应助被活泼的枕头采纳,获得10
6秒前
xucc发布了新的文献求助10
6秒前
喵喵拳发布了新的文献求助10
6秒前
6秒前
super完成签到,获得积分10
6秒前
parad1se完成签到,获得积分10
7秒前
憨子吧完成签到,获得积分10
7秒前
Yy完成签到 ,获得积分10
8秒前
岁岁平安完成签到,获得积分10
9秒前
9秒前
10秒前
研友_VZG7GZ的应助被Luxi采纳,获得10
10秒前
10秒前
荼蘼发布了新的文献求助10
10秒前
CodeCraft的应助被老年学术废物采纳,获得10
10秒前
10秒前
wywy发布了新的文献求助10
11秒前
qiuqiu815777完成签到,获得积分10
11秒前
CodeCraft的应助被zzz采纳,获得10
11秒前
卷卷完成签到 ,获得积分10
11秒前
DW的应助被tang采纳,获得10
13秒前
Zhangyugang666完成签到 ,获得积分10
14秒前
Abracadabra的应助被Eli采纳,获得10
15秒前
mukou发布了新的文献求助10
15秒前
15秒前
活泼的枕头完成签到,获得积分10
15秒前
期待发布了新的文献求助20
16秒前
16秒前
喵喵拳完成签到,获得积分10
16秒前
4645发布了新的文献求助10
16秒前
16秒前
黎洱完成签到 ,获得积分10
16秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566975
关于积分的说明 21789458
捐赠科研通 7769647
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241